nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—SLC22A5—ulcerative colitis	0.448	1	CbGaD
Norfloxacin—SLC22A5—Nicotine—ulcerative colitis	0.0565	0.134	CbGbCtD
Norfloxacin—CYP2A6—Nicotine—ulcerative colitis	0.043	0.102	CbGbCtD
Norfloxacin—CYP1A1—Nicotine—ulcerative colitis	0.0367	0.0873	CbGbCtD
Norfloxacin—CYP1A1—Cholecalciferol—ulcerative colitis	0.0329	0.0783	CbGbCtD
Norfloxacin—CYP2A6—Prednisolone—ulcerative colitis	0.0283	0.0673	CbGbCtD
Norfloxacin—CYP3A4—Budesonide—ulcerative colitis	0.0197	0.0469	CbGbCtD
Norfloxacin—CYP3A7—Hydrocortisone—ulcerative colitis	0.0183	0.0436	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Hydrocortisone—ulcerative colitis	0.0183	0.0436	CbGbCtD
Norfloxacin—CYP3A5—Sulfasalazine—ulcerative colitis	0.0171	0.0408	CbGbCtD
Norfloxacin—CYP2A6—Dexamethasone—ulcerative colitis	0.0167	0.0397	CbGbCtD
Norfloxacin—CYP1A2—Nicotine—ulcerative colitis	0.0164	0.039	CbGbCtD
Norfloxacin—CYP1A1—Dexamethasone—ulcerative colitis	0.0142	0.0339	CbGbCtD
Norfloxacin—CYP3A5—Hydrocortisone—ulcerative colitis	0.0137	0.0327	CbGbCtD
Norfloxacin—CYP3A7—Dexamethasone—ulcerative colitis	0.0114	0.0271	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Dexamethasone—ulcerative colitis	0.0114	0.0271	CbGbCtD
Norfloxacin—CYP3A4—Methylprednisolone—ulcerative colitis	0.00881	0.021	CbGbCtD
Norfloxacin—CYP3A4—Nicotine—ulcerative colitis	0.00859	0.0204	CbGbCtD
Norfloxacin—CYP3A5—Dexamethasone—ulcerative colitis	0.00855	0.0203	CbGbCtD
Norfloxacin—CYP3A4—Cholecalciferol—ulcerative colitis	0.0077	0.0183	CbGbCtD
Norfloxacin—CYP3A4—Triamcinolone—ulcerative colitis	0.00668	0.0159	CbGbCtD
Norfloxacin—CYP3A4—Betamethasone—ulcerative colitis	0.00573	0.0136	CbGbCtD
Norfloxacin—CYP3A4—Prednisolone—ulcerative colitis	0.00565	0.0135	CbGbCtD
Norfloxacin—CYP3A4—Hydrocortisone—ulcerative colitis	0.00536	0.0128	CbGbCtD
Norfloxacin—CYP3A4—Prednisone—ulcerative colitis	0.00534	0.0127	CbGbCtD
Norfloxacin—CYP3A4—Dexamethasone—ulcerative colitis	0.00333	0.00793	CbGbCtD
Norfloxacin—SLC22A5—Organic cation transport—SLC22A4—ulcerative colitis	0.00095	0.155	CbGpPWpGaD
Norfloxacin—Levofloxacin—SLC22A4—ulcerative colitis	0.000851	0.223	CrCbGaD
Norfloxacin—Ofloxacin—SLC22A4—ulcerative colitis	0.000851	0.223	CrCbGaD
Norfloxacin—Lomefloxacin—SLC22A5—ulcerative colitis	0.000749	0.196	CrCbGaD
Norfloxacin—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A4—ulcerative colitis	0.000644	0.105	CbGpPWpGaD
Norfloxacin—Ofloxacin—SLC22A5—ulcerative colitis	0.00064	0.168	CrCbGaD
Norfloxacin—TOP2A—Methyldopa—Mesalazine—ulcerative colitis	0.000594	0.421	CbGdCrCtD
Norfloxacin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—ulcerative colitis	0.000486	0.0795	CbGpPWpGaD
Norfloxacin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—ulcerative colitis	0.000486	0.0795	CbGpPWpGaD
Norfloxacin—Gatifloxacin—ALB—ulcerative colitis	0.000386	0.101	CrCbGaD
Norfloxacin—TOP2A—Methyltestosterone—Hydrocortisone—ulcerative colitis	0.000211	0.15	CbGdCrCtD
Norfloxacin—TOP2A—Methyltestosterone—Prednisone—ulcerative colitis	0.000182	0.129	CbGdCrCtD
Norfloxacin—TOP2A—Methyltestosterone—Prednisolone—ulcerative colitis	0.000178	0.126	CbGdCrCtD
Norfloxacin—Levofloxacin—ABCB1—ulcerative colitis	0.000169	0.0444	CrCbGaD
Norfloxacin—Ciprofloxacin—ABCB1—ulcerative colitis	0.000164	0.0429	CrCbGaD
Norfloxacin—TOP2A—Norethindrone—Hydrocortisone—ulcerative colitis	0.000138	0.0975	CbGdCrCtD
Norfloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.000129	0.0211	CbGpPWpGaD
Norfloxacin—CYP2A6—NRF2 pathway—SLC39A11—ulcerative colitis	0.00012	0.0197	CbGpPWpGaD
Norfloxacin—Asthenia—Budesonide—ulcerative colitis	0.00011	0.000916	CcSEcCtD
Norfloxacin—Dyspepsia—Mesalazine—ulcerative colitis	0.00011	0.000914	CcSEcCtD
Norfloxacin—TOP2A—Levonorgestrel—Hydrocortisone—ulcerative colitis	0.00011	0.0776	CbGdCrCtD
Norfloxacin—Erythema—Hydrocortisone—ulcerative colitis	0.000109	0.000904	CcSEcCtD
Norfloxacin—Neutropenia—Prednisone—ulcerative colitis	0.000109	0.000903	CcSEcCtD
Norfloxacin—Pruritus—Budesonide—ulcerative colitis	0.000109	0.000903	CcSEcCtD
Norfloxacin—Decreased appetite—Mesalazine—ulcerative colitis	0.000109	0.000902	CcSEcCtD
Norfloxacin—Abdominal pain—Azathioprine—ulcerative colitis	0.000108	0.000901	CcSEcCtD
Norfloxacin—Body temperature increased—Azathioprine—ulcerative colitis	0.000108	0.000901	CcSEcCtD
Norfloxacin—Fatigue—Mesalazine—ulcerative colitis	0.000108	0.000895	CcSEcCtD
Norfloxacin—Constipation—Mesalazine—ulcerative colitis	0.000107	0.000888	CcSEcCtD
Norfloxacin—Hallucination—Betamethasone—ulcerative colitis	0.000106	0.000883	CcSEcCtD
Norfloxacin—Hallucination—Dexamethasone—ulcerative colitis	0.000106	0.000883	CcSEcCtD
Norfloxacin—Diarrhoea—Budesonide—ulcerative colitis	0.000105	0.000873	CcSEcCtD
Norfloxacin—Vision blurred—Prednisolone—ulcerative colitis	0.000105	0.000873	CcSEcCtD
Norfloxacin—Visual impairment—Betamethasone—ulcerative colitis	0.000103	0.000855	CcSEcCtD
Norfloxacin—Visual impairment—Dexamethasone—ulcerative colitis	0.000103	0.000855	CcSEcCtD
Norfloxacin—Feeling abnormal—Mesalazine—ulcerative colitis	0.000103	0.000855	CcSEcCtD
Norfloxacin—Erythema—Triamcinolone—ulcerative colitis	0.000103	0.000851	CcSEcCtD
Norfloxacin—Erythema—Methylprednisolone—ulcerative colitis	0.000102	0.00085	CcSEcCtD
Norfloxacin—Acute coronary syndrome—Prednisone—ulcerative colitis	0.000102	0.000849	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000102	0.000849	CcSEcCtD
Norfloxacin—Angioedema—Prednisolone—ulcerative colitis	0.000102	0.000846	CcSEcCtD
Norfloxacin—Myocardial infarction—Prednisone—ulcerative colitis	0.000102	0.000844	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Prednisone—ulcerative colitis	0.000102	0.000844	CcSEcCtD
Norfloxacin—Dizziness—Budesonide—ulcerative colitis	0.000102	0.000844	CcSEcCtD
Norfloxacin—Hypersensitivity—Azathioprine—ulcerative colitis	0.000101	0.000839	CcSEcCtD
Norfloxacin—Dysgeusia—Triamcinolone—ulcerative colitis	0.0001	0.000834	CcSEcCtD
Norfloxacin—Vertigo—Prednisolone—ulcerative colitis	0.0001	0.000832	CcSEcCtD
Norfloxacin—Angioedema—Hydrocortisone—ulcerative colitis	9.95e-05	0.000826	CcSEcCtD
Norfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	9.95e-05	0.0163	CbGpPWpGaD
Norfloxacin—Urticaria—Mesalazine—ulcerative colitis	9.93e-05	0.000825	CcSEcCtD
Norfloxacin—Back pain—Triamcinolone—ulcerative colitis	9.92e-05	0.000824	CcSEcCtD
Norfloxacin—Body temperature increased—Mesalazine—ulcerative colitis	9.88e-05	0.00082	CcSEcCtD
Norfloxacin—Abdominal pain—Mesalazine—ulcerative colitis	9.88e-05	0.00082	CcSEcCtD
Norfloxacin—Vertigo—Hydrocortisone—ulcerative colitis	9.78e-05	0.000812	CcSEcCtD
Norfloxacin—Vomiting—Budesonide—ulcerative colitis	9.77e-05	0.000811	CcSEcCtD
Norfloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	9.74e-05	0.0159	CbGpPWpGaD
Norfloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	9.74e-05	0.0159	CbGpPWpGaD
Norfloxacin—Rash—Budesonide—ulcerative colitis	9.69e-05	0.000805	CcSEcCtD
Norfloxacin—Dermatitis—Budesonide—ulcerative colitis	9.68e-05	0.000804	CcSEcCtD
Norfloxacin—Convulsion—Prednisolone—ulcerative colitis	9.66e-05	0.000802	CcSEcCtD
Norfloxacin—Headache—Budesonide—ulcerative colitis	9.63e-05	0.000799	CcSEcCtD
Norfloxacin—Convulsion—Hydrocortisone—ulcerative colitis	9.44e-05	0.000784	CcSEcCtD
Norfloxacin—Diarrhoea—Azathioprine—ulcerative colitis	9.39e-05	0.00078	CcSEcCtD
Norfloxacin—Angioedema—Triamcinolone—ulcerative colitis	9.37e-05	0.000778	CcSEcCtD
Norfloxacin—Angioedema—Methylprednisolone—ulcerative colitis	9.35e-05	0.000776	CcSEcCtD
Norfloxacin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—ulcerative colitis	9.32e-05	0.0152	CbGpPWpGaD
Norfloxacin—Erythema—Dexamethasone—ulcerative colitis	9.3e-05	0.000773	CcSEcCtD
Norfloxacin—Erythema—Betamethasone—ulcerative colitis	9.3e-05	0.000773	CcSEcCtD
Norfloxacin—Myalgia—Hydrocortisone—ulcerative colitis	9.27e-05	0.00077	CcSEcCtD
Norfloxacin—Hallucination—Prednisone—ulcerative colitis	9.26e-05	0.000769	CcSEcCtD
Norfloxacin—Anxiety—Hydrocortisone—ulcerative colitis	9.24e-05	0.000767	CcSEcCtD
Norfloxacin—Vertigo—Triamcinolone—ulcerative colitis	9.21e-05	0.000765	CcSEcCtD
Norfloxacin—Hypersensitivity—Mesalazine—ulcerative colitis	9.21e-05	0.000765	CcSEcCtD
Norfloxacin—Vertigo—Methylprednisolone—ulcerative colitis	9.19e-05	0.000763	CcSEcCtD
Norfloxacin—Nausea—Budesonide—ulcerative colitis	9.13e-05	0.000758	CcSEcCtD
Norfloxacin—Anaphylactic shock—Prednisolone—ulcerative colitis	9.1e-05	0.000756	CcSEcCtD
Norfloxacin—Oedema—Prednisolone—ulcerative colitis	9.1e-05	0.000756	CcSEcCtD
Norfloxacin—Dizziness—Azathioprine—ulcerative colitis	9.07e-05	0.000753	CcSEcCtD
Norfloxacin—Asthenia—Mesalazine—ulcerative colitis	8.97e-05	0.000745	CcSEcCtD
Norfloxacin—Anaphylactic shock—Hydrocortisone—ulcerative colitis	8.89e-05	0.000738	CcSEcCtD
Norfloxacin—Oedema—Hydrocortisone—ulcerative colitis	8.89e-05	0.000738	CcSEcCtD
Norfloxacin—Convulsion—Triamcinolone—ulcerative colitis	8.88e-05	0.000738	CcSEcCtD
Norfloxacin—Convulsion—Methylprednisolone—ulcerative colitis	8.86e-05	0.000736	CcSEcCtD
Norfloxacin—Pruritus—Mesalazine—ulcerative colitis	8.84e-05	0.000734	CcSEcCtD
Norfloxacin—Hyperhidrosis—Prednisolone—ulcerative colitis	8.8e-05	0.000731	CcSEcCtD
Norfloxacin—Myalgia—Triamcinolone—ulcerative colitis	8.73e-05	0.000725	CcSEcCtD
Norfloxacin—Vomiting—Azathioprine—ulcerative colitis	8.72e-05	0.000724	CcSEcCtD
Norfloxacin—Arthralgia—Methylprednisolone—ulcerative colitis	8.71e-05	0.000723	CcSEcCtD
Norfloxacin—Myalgia—Methylprednisolone—ulcerative colitis	8.71e-05	0.000723	CcSEcCtD
Norfloxacin—Anxiety—Methylprednisolone—ulcerative colitis	8.68e-05	0.000721	CcSEcCtD
Norfloxacin—Rash—Azathioprine—ulcerative colitis	8.65e-05	0.000718	CcSEcCtD
Norfloxacin—Dermatitis—Azathioprine—ulcerative colitis	8.64e-05	0.000718	CcSEcCtD
Norfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—ulcerative colitis	8.6e-05	0.0141	CbGpPWpGaD
Norfloxacin—Headache—Azathioprine—ulcerative colitis	8.6e-05	0.000714	CcSEcCtD
Norfloxacin—Hyperhidrosis—Hydrocortisone—ulcerative colitis	8.59e-05	0.000713	CcSEcCtD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	8.56e-05	0.014	CbGpPWpGaD
Norfloxacin—Diarrhoea—Mesalazine—ulcerative colitis	8.55e-05	0.00071	CcSEcCtD
Norfloxacin—Dry mouth—Triamcinolone—ulcerative colitis	8.54e-05	0.000709	CcSEcCtD
Norfloxacin—Angioedema—Betamethasone—ulcerative colitis	8.5e-05	0.000706	CcSEcCtD
Norfloxacin—Angioedema—Dexamethasone—ulcerative colitis	8.5e-05	0.000706	CcSEcCtD
Norfloxacin—Anorexia—Hydrocortisone—ulcerative colitis	8.47e-05	0.000704	CcSEcCtD
Norfloxacin—Confusional state—Methylprednisolone—ulcerative colitis	8.42e-05	0.000699	CcSEcCtD
Norfloxacin—Anaphylactic shock—Triamcinolone—ulcerative colitis	8.37e-05	0.000695	CcSEcCtD
Norfloxacin—Oedema—Triamcinolone—ulcerative colitis	8.37e-05	0.000695	CcSEcCtD
Norfloxacin—Vertigo—Dexamethasone—ulcerative colitis	8.36e-05	0.000694	CcSEcCtD
Norfloxacin—Vertigo—Betamethasone—ulcerative colitis	8.36e-05	0.000694	CcSEcCtD
Norfloxacin—Anaphylactic shock—Methylprednisolone—ulcerative colitis	8.35e-05	0.000693	CcSEcCtD
Norfloxacin—Dizziness—Mesalazine—ulcerative colitis	8.26e-05	0.000686	CcSEcCtD
Norfloxacin—Insomnia—Prednisolone—ulcerative colitis	8.23e-05	0.000683	CcSEcCtD
Norfloxacin—Paraesthesia—Prednisolone—ulcerative colitis	8.17e-05	0.000679	CcSEcCtD
Norfloxacin—Nausea—Azathioprine—ulcerative colitis	8.15e-05	0.000677	CcSEcCtD
Norfloxacin—Erythema—Prednisone—ulcerative colitis	8.1e-05	0.000673	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	8.1e-05	0.000672	CcSEcCtD
Norfloxacin—Hyperhidrosis—Triamcinolone—ulcerative colitis	8.09e-05	0.000672	CcSEcCtD
Norfloxacin—Hyperhidrosis—Methylprednisolone—ulcerative colitis	8.07e-05	0.00067	CcSEcCtD
Norfloxacin—Convulsion—Betamethasone—ulcerative colitis	8.06e-05	0.000669	CcSEcCtD
Norfloxacin—Convulsion—Dexamethasone—ulcerative colitis	8.06e-05	0.000669	CcSEcCtD
Norfloxacin—Insomnia—Hydrocortisone—ulcerative colitis	8.04e-05	0.000668	CcSEcCtD
Norfloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	8.03e-05	0.0131	CbGpPWpGaD
Norfloxacin—Paraesthesia—Hydrocortisone—ulcerative colitis	7.98e-05	0.000663	CcSEcCtD
Norfloxacin—Vomiting—Mesalazine—ulcerative colitis	7.95e-05	0.00066	CcSEcCtD
Norfloxacin—Myalgia—Betamethasone—ulcerative colitis	7.92e-05	0.000658	CcSEcCtD
Norfloxacin—Myalgia—Dexamethasone—ulcerative colitis	7.92e-05	0.000658	CcSEcCtD
Norfloxacin—Anxiety—Dexamethasone—ulcerative colitis	7.89e-05	0.000655	CcSEcCtD
Norfloxacin—Anxiety—Betamethasone—ulcerative colitis	7.89e-05	0.000655	CcSEcCtD
Norfloxacin—Rash—Mesalazine—ulcerative colitis	7.88e-05	0.000654	CcSEcCtD
Norfloxacin—Dermatitis—Mesalazine—ulcerative colitis	7.87e-05	0.000654	CcSEcCtD
Norfloxacin—Headache—Mesalazine—ulcerative colitis	7.83e-05	0.00065	CcSEcCtD
Norfloxacin—Dyspepsia—Hydrocortisone—ulcerative colitis	7.82e-05	0.00065	CcSEcCtD
Norfloxacin—Decreased appetite—Hydrocortisone—ulcerative colitis	7.73e-05	0.000642	CcSEcCtD
Norfloxacin—Fatigue—Hydrocortisone—ulcerative colitis	7.66e-05	0.000636	CcSEcCtD
Norfloxacin—Vision blurred—Prednisone—ulcerative colitis	7.64e-05	0.000634	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	7.62e-05	0.000633	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	7.61e-05	0.000632	CcSEcCtD
Norfloxacin—Anaphylactic shock—Betamethasone—ulcerative colitis	7.59e-05	0.000631	CcSEcCtD
Norfloxacin—Anaphylactic shock—Dexamethasone—ulcerative colitis	7.59e-05	0.000631	CcSEcCtD
Norfloxacin—Oedema—Dexamethasone—ulcerative colitis	7.59e-05	0.000631	CcSEcCtD
Norfloxacin—Oedema—Betamethasone—ulcerative colitis	7.59e-05	0.000631	CcSEcCtD
Norfloxacin—Insomnia—Triamcinolone—ulcerative colitis	7.57e-05	0.000629	CcSEcCtD
Norfloxacin—Insomnia—Methylprednisolone—ulcerative colitis	7.55e-05	0.000627	CcSEcCtD
Norfloxacin—Paraesthesia—Triamcinolone—ulcerative colitis	7.51e-05	0.000624	CcSEcCtD
Norfloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	7.51e-05	0.0123	CbGpPWpGaD
Norfloxacin—Feeling abnormal—Prednisolone—ulcerative colitis	7.5e-05	0.000623	CcSEcCtD
Norfloxacin—Paraesthesia—Methylprednisolone—ulcerative colitis	7.5e-05	0.000623	CcSEcCtD
Norfloxacin—Dyspnoea—Triamcinolone—ulcerative colitis	7.46e-05	0.00062	CcSEcCtD
Norfloxacin—Agitation—Prednisone—ulcerative colitis	7.45e-05	0.000618	CcSEcCtD
Norfloxacin—Thrombocytopenia—Betamethasone—ulcerative colitis	7.43e-05	0.000617	CcSEcCtD
Norfloxacin—Thrombocytopenia—Dexamethasone—ulcerative colitis	7.43e-05	0.000617	CcSEcCtD
Norfloxacin—Nausea—Mesalazine—ulcerative colitis	7.42e-05	0.000616	CcSEcCtD
Norfloxacin—Angioedema—Prednisone—ulcerative colitis	7.4e-05	0.000615	CcSEcCtD
Norfloxacin—Dyspepsia—Triamcinolone—ulcerative colitis	7.37e-05	0.000612	CcSEcCtD
Norfloxacin—Dyspepsia—Methylprednisolone—ulcerative colitis	7.35e-05	0.00061	CcSEcCtD
Norfloxacin—Hyperhidrosis—Dexamethasone—ulcerative colitis	7.34e-05	0.00061	CcSEcCtD
Norfloxacin—Hyperhidrosis—Betamethasone—ulcerative colitis	7.34e-05	0.00061	CcSEcCtD
Norfloxacin—Feeling abnormal—Hydrocortisone—ulcerative colitis	7.32e-05	0.000608	CcSEcCtD
Norfloxacin—Vertigo—Prednisone—ulcerative colitis	7.28e-05	0.000605	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	7.27e-05	0.000604	CcSEcCtD
Norfloxacin—Anorexia—Betamethasone—ulcerative colitis	7.24e-05	0.000601	CcSEcCtD
Norfloxacin—Anorexia—Dexamethasone—ulcerative colitis	7.24e-05	0.000601	CcSEcCtD
Norfloxacin—Urticaria—Prednisolone—ulcerative colitis	7.23e-05	0.0006	CcSEcCtD
Norfloxacin—Fatigue—Triamcinolone—ulcerative colitis	7.22e-05	0.000599	CcSEcCtD
Norfloxacin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	7.21e-05	0.0118	CbGpPWpGaD
Norfloxacin—Fatigue—Methylprednisolone—ulcerative colitis	7.2e-05	0.000598	CcSEcCtD
Norfloxacin—Urticaria—Hydrocortisone—ulcerative colitis	7.06e-05	0.000586	CcSEcCtD
Norfloxacin—Abdominal pain—Hydrocortisone—ulcerative colitis	7.03e-05	0.000583	CcSEcCtD
Norfloxacin—Body temperature increased—Hydrocortisone—ulcerative colitis	7.03e-05	0.000583	CcSEcCtD
Norfloxacin—Convulsion—Prednisone—ulcerative colitis	7.02e-05	0.000583	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	6.92e-05	0.000574	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	6.92e-05	0.000574	CcSEcCtD
Norfloxacin—Myalgia—Prednisone—ulcerative colitis	6.9e-05	0.000573	CcSEcCtD
Norfloxacin—Arthralgia—Prednisone—ulcerative colitis	6.9e-05	0.000573	CcSEcCtD
Norfloxacin—Feeling abnormal—Triamcinolone—ulcerative colitis	6.9e-05	0.000573	CcSEcCtD
Norfloxacin—Feeling abnormal—Methylprednisolone—ulcerative colitis	6.88e-05	0.000571	CcSEcCtD
Norfloxacin—Anxiety—Prednisone—ulcerative colitis	6.87e-05	0.000571	CcSEcCtD
Norfloxacin—Insomnia—Dexamethasone—ulcerative colitis	6.87e-05	0.00057	CcSEcCtD
Norfloxacin—Insomnia—Betamethasone—ulcerative colitis	6.87e-05	0.00057	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	6.83e-05	0.000567	CcSEcCtD
Norfloxacin—Paraesthesia—Betamethasone—ulcerative colitis	6.82e-05	0.000566	CcSEcCtD
Norfloxacin—Paraesthesia—Dexamethasone—ulcerative colitis	6.82e-05	0.000566	CcSEcCtD
Norfloxacin—Hypersensitivity—Prednisolone—ulcerative colitis	6.7e-05	0.000557	CcSEcCtD
Norfloxacin—Dyspepsia—Dexamethasone—ulcerative colitis	6.68e-05	0.000555	CcSEcCtD
Norfloxacin—Dyspepsia—Betamethasone—ulcerative colitis	6.68e-05	0.000555	CcSEcCtD
Norfloxacin—Urticaria—Triamcinolone—ulcerative colitis	6.65e-05	0.000552	CcSEcCtD
Norfloxacin—Urticaria—Methylprednisolone—ulcerative colitis	6.63e-05	0.000551	CcSEcCtD
Norfloxacin—Body temperature increased—Triamcinolone—ulcerative colitis	6.62e-05	0.000549	CcSEcCtD
Norfloxacin—Anaphylactic shock—Prednisone—ulcerative colitis	6.61e-05	0.000549	CcSEcCtD
Norfloxacin—Oedema—Prednisone—ulcerative colitis	6.61e-05	0.000549	CcSEcCtD
Norfloxacin—Abdominal pain—Methylprednisolone—ulcerative colitis	6.6e-05	0.000548	CcSEcCtD
Norfloxacin—Decreased appetite—Betamethasone—ulcerative colitis	6.6e-05	0.000548	CcSEcCtD
Norfloxacin—Decreased appetite—Dexamethasone—ulcerative colitis	6.6e-05	0.000548	CcSEcCtD
Norfloxacin—Hypersensitivity—Hydrocortisone—ulcerative colitis	6.55e-05	0.000544	CcSEcCtD
Norfloxacin—Fatigue—Dexamethasone—ulcerative colitis	6.55e-05	0.000544	CcSEcCtD
Norfloxacin—Fatigue—Betamethasone—ulcerative colitis	6.55e-05	0.000544	CcSEcCtD
Norfloxacin—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	6.49e-05	0.0106	CbGpPWpGaD
Norfloxacin—Hyperhidrosis—Prednisone—ulcerative colitis	6.39e-05	0.000531	CcSEcCtD
Norfloxacin—Asthenia—Hydrocortisone—ulcerative colitis	6.38e-05	0.00053	CcSEcCtD
Norfloxacin—Anorexia—Prednisone—ulcerative colitis	6.3e-05	0.000523	CcSEcCtD
Norfloxacin—Pruritus—Hydrocortisone—ulcerative colitis	6.29e-05	0.000522	CcSEcCtD
Norfloxacin—Feeling abnormal—Betamethasone—ulcerative colitis	6.26e-05	0.00052	CcSEcCtD
Norfloxacin—Feeling abnormal—Dexamethasone—ulcerative colitis	6.26e-05	0.00052	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Betamethasone—ulcerative colitis	6.21e-05	0.000516	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Dexamethasone—ulcerative colitis	6.21e-05	0.000516	CcSEcCtD
Norfloxacin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—ulcerative colitis	6.18e-05	0.0101	CbGpPWpGaD
Norfloxacin—Hypersensitivity—Triamcinolone—ulcerative colitis	6.17e-05	0.000512	CcSEcCtD
Norfloxacin—Hypersensitivity—Methylprednisolone—ulcerative colitis	6.15e-05	0.000511	CcSEcCtD
Norfloxacin—Diarrhoea—Hydrocortisone—ulcerative colitis	6.08e-05	0.000505	CcSEcCtD
Norfloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	6.06e-05	0.00991	CbGpPWpGaD
Norfloxacin—Urticaria—Betamethasone—ulcerative colitis	6.03e-05	0.000501	CcSEcCtD
Norfloxacin—Urticaria—Dexamethasone—ulcerative colitis	6.03e-05	0.000501	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Prednisone—ulcerative colitis	6.02e-05	0.0005	CcSEcCtD
Norfloxacin—Dizziness—Prednisolone—ulcerative colitis	6.02e-05	0.0005	CcSEcCtD
Norfloxacin—Asthenia—Triamcinolone—ulcerative colitis	6e-05	0.000499	CcSEcCtD
Norfloxacin—Body temperature increased—Dexamethasone—ulcerative colitis	6e-05	0.000498	CcSEcCtD
Norfloxacin—Abdominal pain—Dexamethasone—ulcerative colitis	6e-05	0.000498	CcSEcCtD
Norfloxacin—Body temperature increased—Betamethasone—ulcerative colitis	6e-05	0.000498	CcSEcCtD
Norfloxacin—Abdominal pain—Betamethasone—ulcerative colitis	6e-05	0.000498	CcSEcCtD
Norfloxacin—Asthenia—Methylprednisolone—ulcerative colitis	5.99e-05	0.000497	CcSEcCtD
Norfloxacin—Insomnia—Prednisone—ulcerative colitis	5.98e-05	0.000497	CcSEcCtD
Norfloxacin—Paraesthesia—Prednisone—ulcerative colitis	5.94e-05	0.000493	CcSEcCtD
Norfloxacin—Pruritus—Triamcinolone—ulcerative colitis	5.92e-05	0.000492	CcSEcCtD
Norfloxacin—Pruritus—Methylprednisolone—ulcerative colitis	5.91e-05	0.000491	CcSEcCtD
Norfloxacin—Dizziness—Hydrocortisone—ulcerative colitis	5.88e-05	0.000488	CcSEcCtD
Norfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	5.86e-05	0.00958	CbGpPWpGaD
Norfloxacin—Dyspepsia—Prednisone—ulcerative colitis	5.82e-05	0.000483	CcSEcCtD
Norfloxacin—Decreased appetite—Prednisone—ulcerative colitis	5.75e-05	0.000477	CcSEcCtD
Norfloxacin—Rash—Prednisolone—ulcerative colitis	5.74e-05	0.000476	CcSEcCtD
Norfloxacin—Dermatitis—Prednisolone—ulcerative colitis	5.73e-05	0.000476	CcSEcCtD
Norfloxacin—Diarrhoea—Methylprednisolone—ulcerative colitis	5.71e-05	0.000474	CcSEcCtD
Norfloxacin—Fatigue—Prednisone—ulcerative colitis	5.7e-05	0.000473	CcSEcCtD
Norfloxacin—Headache—Prednisolone—ulcerative colitis	5.7e-05	0.000473	CcSEcCtD
Norfloxacin—Constipation—Prednisone—ulcerative colitis	5.65e-05	0.00047	CcSEcCtD
Norfloxacin—Vomiting—Hydrocortisone—ulcerative colitis	5.65e-05	0.000469	CcSEcCtD
Norfloxacin—Rash—Hydrocortisone—ulcerative colitis	5.6e-05	0.000465	CcSEcCtD
Norfloxacin—Dermatitis—Hydrocortisone—ulcerative colitis	5.6e-05	0.000465	CcSEcCtD
Norfloxacin—Headache—Hydrocortisone—ulcerative colitis	5.57e-05	0.000462	CcSEcCtD
Norfloxacin—Dizziness—Triamcinolone—ulcerative colitis	5.53e-05	0.00046	CcSEcCtD
Norfloxacin—Dizziness—Methylprednisolone—ulcerative colitis	5.52e-05	0.000459	CcSEcCtD
Norfloxacin—Feeling abnormal—Prednisone—ulcerative colitis	5.45e-05	0.000453	CcSEcCtD
Norfloxacin—Asthenia—Dexamethasone—ulcerative colitis	5.45e-05	0.000452	CcSEcCtD
Norfloxacin—Asthenia—Betamethasone—ulcerative colitis	5.45e-05	0.000452	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Prednisone—ulcerative colitis	5.41e-05	0.000449	CcSEcCtD
Norfloxacin—Nausea—Prednisolone—ulcerative colitis	5.41e-05	0.000449	CcSEcCtD
Norfloxacin—Pruritus—Dexamethasone—ulcerative colitis	5.37e-05	0.000446	CcSEcCtD
Norfloxacin—Pruritus—Betamethasone—ulcerative colitis	5.37e-05	0.000446	CcSEcCtD
Norfloxacin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	5.36e-05	0.00877	CbGpPWpGaD
Norfloxacin—Vomiting—Triamcinolone—ulcerative colitis	5.32e-05	0.000442	CcSEcCtD
Norfloxacin—Vomiting—Methylprednisolone—ulcerative colitis	5.31e-05	0.000441	CcSEcCtD
Norfloxacin—Nausea—Hydrocortisone—ulcerative colitis	5.28e-05	0.000438	CcSEcCtD
Norfloxacin—Rash—Triamcinolone—ulcerative colitis	5.28e-05	0.000438	CcSEcCtD
Norfloxacin—Dermatitis—Triamcinolone—ulcerative colitis	5.27e-05	0.000438	CcSEcCtD
Norfloxacin—Rash—Methylprednisolone—ulcerative colitis	5.26e-05	0.000437	CcSEcCtD
Norfloxacin—Dermatitis—Methylprednisolone—ulcerative colitis	5.26e-05	0.000437	CcSEcCtD
Norfloxacin—Urticaria—Prednisone—ulcerative colitis	5.25e-05	0.000436	CcSEcCtD
Norfloxacin—Headache—Triamcinolone—ulcerative colitis	5.24e-05	0.000435	CcSEcCtD
Norfloxacin—Headache—Methylprednisolone—ulcerative colitis	5.23e-05	0.000434	CcSEcCtD
Norfloxacin—Abdominal pain—Prednisone—ulcerative colitis	5.23e-05	0.000434	CcSEcCtD
Norfloxacin—Body temperature increased—Prednisone—ulcerative colitis	5.23e-05	0.000434	CcSEcCtD
Norfloxacin—Diarrhoea—Betamethasone—ulcerative colitis	5.2e-05	0.000431	CcSEcCtD
Norfloxacin—Diarrhoea—Dexamethasone—ulcerative colitis	5.2e-05	0.000431	CcSEcCtD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CEP72—ulcerative colitis	5.14e-05	0.00841	CbGpPWpGaD
Norfloxacin—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	5.11e-05	0.00836	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	5.05e-05	0.00826	CbGpPWpGaD
Norfloxacin—Dizziness—Dexamethasone—ulcerative colitis	5.02e-05	0.000417	CcSEcCtD
Norfloxacin—Dizziness—Betamethasone—ulcerative colitis	5.02e-05	0.000417	CcSEcCtD
Norfloxacin—Nausea—Triamcinolone—ulcerative colitis	4.97e-05	0.000413	CcSEcCtD
Norfloxacin—Nausea—Methylprednisolone—ulcerative colitis	4.96e-05	0.000412	CcSEcCtD
Norfloxacin—CYP3A7—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	4.95e-05	0.0081	CbGpPWpGaD
Norfloxacin—Hypersensitivity—Prednisone—ulcerative colitis	4.87e-05	0.000405	CcSEcCtD
Norfloxacin—CYP1A1—Arachidonic acid metabolism—PTGS1—ulcerative colitis	4.83e-05	0.0079	CbGpPWpGaD
Norfloxacin—Vomiting—Betamethasone—ulcerative colitis	4.83e-05	0.000401	CcSEcCtD
Norfloxacin—Vomiting—Dexamethasone—ulcerative colitis	4.83e-05	0.000401	CcSEcCtD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	4.8e-05	0.00785	CbGpPWpGaD
Norfloxacin—Rash—Dexamethasone—ulcerative colitis	4.79e-05	0.000398	CcSEcCtD
Norfloxacin—Rash—Betamethasone—ulcerative colitis	4.79e-05	0.000398	CcSEcCtD
Norfloxacin—Dermatitis—Betamethasone—ulcerative colitis	4.78e-05	0.000397	CcSEcCtD
Norfloxacin—Dermatitis—Dexamethasone—ulcerative colitis	4.78e-05	0.000397	CcSEcCtD
Norfloxacin—Headache—Betamethasone—ulcerative colitis	4.76e-05	0.000395	CcSEcCtD
Norfloxacin—Headache—Dexamethasone—ulcerative colitis	4.76e-05	0.000395	CcSEcCtD
Norfloxacin—Asthenia—Prednisone—ulcerative colitis	4.74e-05	0.000394	CcSEcCtD
Norfloxacin—Pruritus—Prednisone—ulcerative colitis	4.68e-05	0.000389	CcSEcCtD
Norfloxacin—TOP2A—Cell Cycle—CEP72—ulcerative colitis	4.6e-05	0.00752	CbGpPWpGaD
Norfloxacin—CYP2A6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	4.54e-05	0.00742	CbGpPWpGaD
Norfloxacin—Diarrhoea—Prednisone—ulcerative colitis	4.52e-05	0.000376	CcSEcCtD
Norfloxacin—Nausea—Betamethasone—ulcerative colitis	4.51e-05	0.000375	CcSEcCtD
Norfloxacin—Nausea—Dexamethasone—ulcerative colitis	4.51e-05	0.000375	CcSEcCtD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	4.5e-05	0.00735	CbGpPWpGaD
Norfloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	4.42e-05	0.00723	CbGpPWpGaD
Norfloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	4.42e-05	0.00723	CbGpPWpGaD
Norfloxacin—Dizziness—Prednisone—ulcerative colitis	4.37e-05	0.000363	CcSEcCtD
Norfloxacin—CYP1A1—Estrogen Receptor Pathway—STAT3—ulcerative colitis	4.24e-05	0.00693	CbGpPWpGaD
Norfloxacin—Vomiting—Prednisone—ulcerative colitis	4.2e-05	0.000349	CcSEcCtD
Norfloxacin—Rash—Prednisone—ulcerative colitis	4.17e-05	0.000346	CcSEcCtD
Norfloxacin—Dermatitis—Prednisone—ulcerative colitis	4.17e-05	0.000346	CcSEcCtD
Norfloxacin—Headache—Prednisone—ulcerative colitis	4.14e-05	0.000344	CcSEcCtD
Norfloxacin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	3.94e-05	0.00645	CbGpPWpGaD
Norfloxacin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	3.94e-05	0.00644	CbGpPWpGaD
Norfloxacin—Nausea—Prednisone—ulcerative colitis	3.93e-05	0.000326	CcSEcCtD
Norfloxacin—TOP2A—Gastric Cancer Network 2—TP53—ulcerative colitis	3.92e-05	0.0064	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	3.81e-05	0.00624	CbGpPWpGaD
Norfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	3.65e-05	0.00597	CbGpPWpGaD
Norfloxacin—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	3.58e-05	0.00586	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—GHRL—ulcerative colitis	3.58e-05	0.00585	CbGpPWpGaD
Norfloxacin—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	3.38e-05	0.00553	CbGpPWpGaD
Norfloxacin—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	3.08e-05	0.00503	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	3.06e-05	0.005	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	2.98e-05	0.00487	CbGpPWpGaD
Norfloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	2.94e-05	0.0048	CbGpPWpGaD
Norfloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	2.93e-05	0.00479	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	2.81e-05	0.00459	CbGpPWpGaD
Norfloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	2.76e-05	0.0045	CbGpPWpGaD
Norfloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	2.7e-05	0.00442	CbGpPWpGaD
Norfloxacin—CYP3A7—Biological oxidations—PTGS1—ulcerative colitis	2.63e-05	0.0043	CbGpPWpGaD
Norfloxacin—CYP1A1—Melatonin metabolism and effects—NFKB1—ulcerative colitis	2.48e-05	0.00406	CbGpPWpGaD
Norfloxacin—CYP1A1—Oxidative Stress—NFKB1—ulcerative colitis	2.42e-05	0.00395	CbGpPWpGaD
Norfloxacin—CYP2A6—Biological oxidations—PTGS1—ulcerative colitis	2.41e-05	0.00394	CbGpPWpGaD
Norfloxacin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	2.38e-05	0.00389	CbGpPWpGaD
Norfloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	2.27e-05	0.0037	CbGpPWpGaD
Norfloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	2.26e-05	0.0037	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	2.25e-05	0.00368	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	2.25e-05	0.00368	CbGpPWpGaD
Norfloxacin—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	2.16e-05	0.00353	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	2.06e-05	0.00337	CbGpPWpGaD
Norfloxacin—CYP2A6—Fluoropyrimidine Activity—TP53—ulcerative colitis	2.06e-05	0.00337	CbGpPWpGaD
Norfloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	2.04e-05	0.00334	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	2.04e-05	0.00333	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	1.98e-05	0.00323	CbGpPWpGaD
Norfloxacin—CYP3A5—Biological oxidations—PTGS1—ulcerative colitis	1.9e-05	0.00311	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—PPARG—ulcerative colitis	1.87e-05	0.00307	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.86e-05	0.00303	CbGpPWpGaD
Norfloxacin—CYP1A1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	1.85e-05	0.00303	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	1.84e-05	0.00301	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	1.83e-05	0.003	CbGpPWpGaD
Norfloxacin—CYP1A1—Biological oxidations—PTGS1—ulcerative colitis	1.8e-05	0.00294	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	1.72e-05	0.00281	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ulcerative colitis	1.72e-05	0.0028	CbGpPWpGaD
Norfloxacin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	1.67e-05	0.00272	CbGpPWpGaD
Norfloxacin—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	1.58e-05	0.00259	CbGpPWpGaD
Norfloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	1.58e-05	0.00258	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.54e-05	0.00251	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	1.43e-05	0.00234	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.4e-05	0.00229	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	1.34e-05	0.00218	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	1.34e-05	0.00218	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.33e-05	0.00218	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	1.32e-05	0.00215	CbGpPWpGaD
Norfloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—ulcerative colitis	1.31e-05	0.00215	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	1.3e-05	0.00212	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	1.26e-05	0.00206	CbGpPWpGaD
Norfloxacin—CYP1A1—PPARA activates gene expression—PPARG—ulcerative colitis	1.25e-05	0.00205	CbGpPWpGaD
Norfloxacin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	1.23e-05	0.002	CbGpPWpGaD
Norfloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	1.18e-05	0.00193	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	1.17e-05	0.00192	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	1.17e-05	0.00191	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	1.15e-05	0.00187	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.11e-05	0.00182	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	1.09e-05	0.00179	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CHP1—ulcerative colitis	1.08e-05	0.00176	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.07e-05	0.00175	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.04e-05	0.0017	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	9.96e-06	0.00163	CbGpPWpGaD
Norfloxacin—SLC22A6—SLC-mediated transmembrane transport—ALB—ulcerative colitis	9.92e-06	0.00162	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CHP1—ulcerative colitis	9.89e-06	0.00162	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—DLD—ulcerative colitis	9.31e-06	0.00152	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	9.14e-06	0.00149	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	9.12e-06	0.00149	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	8.84e-06	0.00145	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—TP53—ulcerative colitis	8.78e-06	0.00144	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—DLD—ulcerative colitis	8.53e-06	0.0014	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	8.52e-06	0.00139	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	8.52e-06	0.00139	CbGpPWpGaD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	8.44e-06	0.00138	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	8.06e-06	0.00132	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—IL6—ulcerative colitis	8.04e-06	0.00131	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CHP1—ulcerative colitis	7.8e-06	0.00127	CbGpPWpGaD
Norfloxacin—CYP2A6—NRF2 pathway—TGFB1—ulcerative colitis	7.62e-06	0.00125	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	7.52e-06	0.00123	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CHP1—ulcerative colitis	7.37e-06	0.0012	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	6.9e-06	0.00113	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—DLD—ulcerative colitis	6.73e-06	0.0011	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—ulcerative colitis	6.68e-06	0.00109	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—DLD—ulcerative colitis	6.36e-06	0.00104	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.04e-06	0.000824	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CHP1—ulcerative colitis	4.7e-06	0.000768	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS1—ulcerative colitis	4.5e-06	0.000736	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	4.4e-06	0.000719	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS1—ulcerative colitis	4.13e-06	0.000674	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—DLD—ulcerative colitis	4.05e-06	0.000663	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CALM3—ulcerative colitis	4.05e-06	0.000663	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TP53—ulcerative colitis	3.96e-06	0.000647	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CALM3—ulcerative colitis	3.71e-06	0.000607	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CHP1—ulcerative colitis	3.62e-06	0.000593	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.36e-06	0.00055	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS1—ulcerative colitis	3.25e-06	0.000532	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ABCB1—ulcerative colitis	3.15e-06	0.000515	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—DLD—ulcerative colitis	3.13e-06	0.000511	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS1—ulcerative colitis	3.07e-06	0.000503	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.02e-06	0.000494	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ADCY5—ulcerative colitis	2.94e-06	0.000481	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CALM3—ulcerative colitis	2.93e-06	0.000479	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ABCB1—ulcerative colitis	2.89e-06	0.000472	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CALM3—ulcerative colitis	2.77e-06	0.000452	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ADCY5—ulcerative colitis	2.69e-06	0.000441	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.64e-06	0.000432	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ABCB1—ulcerative colitis	2.28e-06	0.000372	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PPARG—ulcerative colitis	2.19e-06	0.000358	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ABCB1—ulcerative colitis	2.15e-06	0.000352	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.14e-06	0.00035	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ADCY5—ulcerative colitis	2.13e-06	0.000347	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPARG—ulcerative colitis	2.01e-06	0.000329	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ADCY5—ulcerative colitis	2.01e-06	0.000328	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ALB—ulcerative colitis	1.97e-06	0.000322	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS1—ulcerative colitis	1.96e-06	0.00032	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.93e-06	0.000315	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ALB—ulcerative colitis	1.81e-06	0.000295	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CALM3—ulcerative colitis	1.76e-06	0.000288	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS2—ulcerative colitis	1.72e-06	0.000282	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.69e-06	0.000276	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPARG—ulcerative colitis	1.58e-06	0.000259	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS2—ulcerative colitis	1.58e-06	0.000258	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.51e-06	0.000247	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPARG—ulcerative colitis	1.5e-06	0.000245	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ALB—ulcerative colitis	1.43e-06	0.000233	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ABCB1—ulcerative colitis	1.37e-06	0.000224	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.36e-06	0.000223	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALB—ulcerative colitis	1.35e-06	0.00022	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ADCY5—ulcerative colitis	1.28e-06	0.000209	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS2—ulcerative colitis	1.25e-06	0.000204	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS2—ulcerative colitis	1.18e-06	0.000193	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.06e-06	0.000173	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ADCY5—ulcerative colitis	9.88e-07	0.000162	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPARG—ulcerative colitis	9.55e-07	0.000156	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALB—ulcerative colitis	8.58e-07	0.00014	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS2—ulcerative colitis	7.51e-07	0.000123	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPARG—ulcerative colitis	7.37e-07	0.00012	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALB—ulcerative colitis	6.63e-07	0.000108	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS2—ulcerative colitis	5.8e-07	9.48e-05	CbGpPWpGaD
